Research reveals some facemasks and respirators worn to protect against COVID-19 contain ferromagnetic components.
The personal protective equipment (PPE) that MRI technologists are wearing to ward off COVID-19 infection could be unsafe for the imaging suite, a new study has found.
Respirators, including N95 masks (called FFP2 or FFP3 in Europe), can contain magnetic components. Consequently, wearing them into the imaging suite can put technologists at risk, said a team led by O.M. Murray, M.D., of Mater Private Hospital in Dublin, Ireland. They published their findings in the June issue of Clinical Radiology.
“Staff accompanying patients with suspected or confirmed COVID-19 are likely to be wearing respirators when they arrive at the MRI room,” Murray’s team wrote. “MRI staff may also be wearing a respirator as part of their personal protective equipment when dealing with these patients. These staff members may not be aware that respirators and facemasks do not have MRI safety documentation and, as such, require testing.”
To determine whether these masks could pose a risk, the team evaluated four respirators:
For the test, the team assessed the respirators with a handheld magnet of less than 1,000 Gauss outside the MRI control area. In addition, they tested the masks on human head phantoms set on the MRI table.
According to test results, the 3M and Kolmi respirators included parts that did respond to the magnet. Halyard did not. Additionally, the aluminum strip on the nasal bridge of the Dahlhausen surgical mask had no significant effect on imaging, and it also exhibited no signs of magnetism.
Consequently, Murray’s team suggested, to maximize safety, technologists would benefit from testing face masks and respirators before putting one on and wearing it into the MRI suite.
“This study has shown that several commercially available respirators contain ferromagnetic components, and are, thus, regarded as ‘MRI unsafe,’” the team said. “The use of these respirators by staff in the MRI room is contraindicated, both for MRI safety reasons and because they offer suboptimal protection against COVID-19 due to torque, causing a break in the seal at mask-user interface.”
FDA Clears Magnetic Resonance Spectroscopy Platform for Non-Invasive Assessment of Brain Chemistry
November 29th 2023BrainSpec Core reportedly offers enhanced sensitivity for low-grade gliomas and may facilitate the diagnosis of conditions including Alzheimer’s disease, multiple sclerosis, and epilepsy.
Study Says Contrast-Enhanced Mammography Offers Comparable Breast Cancer Detection to MRI
November 15th 2023In findings from an enriched cohort of asymptomatic patients with screening-detected abnormalities, researchers found that contrast-enhanced mammography (CEM) was superior to conventional mammography and offered equivalent detection of breast cancer in comparison to breast MRI and abbreviated breast MRI.
Adjunctive Brain Volume Quantification Tool for MRI Gets FDA Clearance
November 14th 2023Providing automated brain volume calculations based on MRI images, NeuroShield’s artificial intelligence (AI)-powered technology may help facilitate treatment for neurodegenerative conditions ranging from Alzheimer’s disease to epilepsy.